EssilorLuxottica Societe Anonyme Revenue 2011-2019 | ESLOY

EssilorLuxottica Societe Anonyme annual/quarterly revenue history and growth rate from 2011 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • EssilorLuxottica Societe Anonyme revenue for the quarter ending June 30, 2019 was $M, a NAN% increase year-over-year.
  • EssilorLuxottica Societe Anonyme revenue for the twelve months ending June 30, 2019 was $0M, a NAN% increase year-over-year.
  • EssilorLuxottica Societe Anonyme annual revenue for 2018 was $12.754B, a 50.65% increase from 2017.
  • EssilorLuxottica Societe Anonyme annual revenue for 2017 was $8.466B, a 7.53% increase from 2016.
  • EssilorLuxottica Societe Anonyme annual revenue for 2016 was $7.873B, a 5.57% increase from 2015.
EssilorLuxottica Societe Anonyme Annual Revenue
(Millions of US $)
2018 $12,754
2017 $8,466
2016 $7,873
2015 $7,458
2014 $7,537
2013 $6,728
2012 $6,416
2011 $5,835
2010 $5,168
EssilorLuxottica Societe Anonyme Quarterly Revenue
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $26.277B $19.479B
EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.686B 23.40
Medtronic (MDT) Ireland $123.215B 16.57
Stryker (SYK) United States $61.179B 19.77
Boston Scientific (BSX) United States $43.868B 19.76
Baxter (BAX) United States $40.667B 24.82
Lonza Group Ag (LZAGY) Switzerland $30.356B 0.00
Coloplast (CLPBY) Denmark $29.419B 45.40
Terumo (TRUMY) Japan $23.940B 29.88
ResMed (RMD) United States $21.189B 36.81
Zimmer Biomet Holdings (ZBH) United States $20.816B 12.81
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $15.108B 0.00
Insulet (PODD) United States $11.175B 683.73
Bio-Rad Laboratories (BIO) United States $10.212B 47.73
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $6.846B 19.69
DiaSorin S.p.A (DSRLF) Italy $6.714B 0.00
Perrigo (PRGO) Ireland $6.335B 11.55
GN STORE NORD (GNNDY) Denmark $5.510B 28.47
Canopy Growth (CGC) Canada $5.296B 0.00
Haemonetics (HAE) United States $5.273B 32.46
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $3.803B 24.84
Quidel (QDEL) United States $3.726B 32.71
Neogen (NEOG) United States $3.131B 53.04
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
NuVasive (NUVA) United States $2.614B 20.21
Agios Pharmaceuticals (AGIO) United States $2.586B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.532B 0.00
Envista Holdings (NVST) United States $2.464B 0.00
National Vision Holdings (EYE) United States $1.777B 29.93
Cardiovascular Systems (CSII) United States $1.219B 0.00
AtriCure (ATRC) United States $1.217B 0.00
TG Therapeutics (TGTX) United States $1.175B 0.00
Aurora Cannabis (ACB) Canada $1.058B 0.00
NanoString Technologies (NSTG) United States $0.993B 0.00
Aphria (APHA) $0.887B 0.00
VAREX IMAGING (VREX) United States $0.814B 16.91
Phibro Animal Health (PAHC) United States $0.810B 16.02
InMode (INMD) Israel $0.779B 0.00
Cerus (CERS) United States $0.707B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.628B 113.00
Omeros (OMER) United States $0.611B 0.00
PetIQ (PETQ) United States $0.605B 16.47
Eagle Pharmaceuticals (EGRX) United States $0.581B 34.52
OraSure Technologies (OSUR) United States $0.502B 62.23
Lantheus Holdings (LNTH) United States $0.501B 11.26
LeMaitre Vascular (LMAT) United States $0.489B 27.52
Surmodics (SRDX) United States $0.465B 53.42
Quanterix (QTRX) United States $0.459B 0.00
Zynex (ZYXI) United States $0.364B 39.64
Owens & Minor (OMI) United States $0.350B 9.57
Vapotherm (VAPO) United States $0.343B 0.00
Organigram Holdings (OGI) Canada $0.338B 0.00
Repro-Med Systems (KRMD) United States $0.318B 200.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Meridian Bioscience (VIVO) United States $0.299B 12.02
MacroGenics (MGNX) United States $0.296B 0.00
HEXO (HEXO) $0.295B 0.00
Exagen (XGN) United States $0.219B 0.00
Cytosorbents (CTSO) United States $0.214B 0.00
Female Health (VERU) United States $0.209B 0.00
BioLife Solutions (BLFS) United States $0.206B 126.00
Rockwell Medical (RMTI) United States $0.169B 0.00
Viemed Healthcare (VMD) United States $0.163B 18.39
InfuSystems Holdings (INFU) United States $0.161B 135.33
Evolus (EOLS) United States $0.152B 0.00
United Health Products (UEEC) United States $0.146B 0.00
Bovie Medical (APYX) United States $0.135B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.093B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
Fonar (FONR) United States $0.091B 6.64
Green Organic Dutchman Holdings (TGODF) Canada $0.078B 0.00
MTech Acquisition (KERN) United States $0.077B 0.00
Brainsway (BWAY) Israel $0.073B 0.00
United-Guardian (UG) United States $0.062B 13.08
Nephros (NEPH) United States $0.057B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00